NCT01596413 2024-07-26
Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years
Kyowa Kirin Co., Ltd.
Phase 1 Withdrawn
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
Kyowa Kirin Co., Ltd.
AstraZeneca
Maxinase Life Sciences Ltd.